Vivimusta 24338-0270

Generic: Bendamustine Hydrochloride

Product NDC

24338-0270

Manufacturer: Azurity Pharmaceuticals, Inc.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 1, 2025
Listing Expires: December 31, 2026
Application: NDA212209

Need to source Vivimusta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bendamustine Hydrochloride	25 mg/mL

Drug Class

Alkylating Activity [MoA]Alkylating Drug [EPC]

Packaging Options(1)

24338-0270-01

1 VIAL, MULTI-DOSE in 1 CARTON (24338-270-01) / 4 mL in 1 VIAL, MULTI-DOSE

View →